Different effects of lipoteichoic acid from C. butyricum and S. aureus on inflammatory responses of HT-29 cells

International Journal of Biological Macromolecules

Volumn 87, Issue , 2016, Pages 481-487

  Wang, Jinbo ^a   Qi, Lili ^a   Wu, Zhige ^a   Mei, Lehe ^a   Wang, Hengzheng ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

HT 29 cells; Inflammatory responses; Lipoteichoic acids

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LIPOTEICHOIC ACID; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TEICHOIC ACID;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CLOSTRIDIUM BUTYRICUM; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MOLECULE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION INITIATION; WESTERN BLOTTING; CELL NUCLEUS; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; HT-29 CELL LINE; METABOLISM; SECRETION (PROCESS); SPECIES DIFFERENCE;

CELL NUCLEUS; CELL SURVIVAL; CLOSTRIDIUM BUTYRICUM; CYTOKINES; HT29 CELLS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; RNA, MESSENGER; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TRANSCRIPTION FACTOR RELA;

EID: 84960853440     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.03.010     Document Type: Article

References (30)

1. Schuijt T.J., van der Poll T., de Vos W.M., Wiersinga W.J. The intestinal microbiota and host immune interactions in the critically ill. Trends Microbiol. 2013, 21:221-229.
2. Belizário J.E., Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front. Microbiol. 2015, 6:1050.
3. Abrahamsson T.R., Wu R.Y., Jenmalm M.C. Gut microbiota and allergy: the importance of the pregnancy period. Pediatr. Res. 2015, 77:214-219.
4. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 2010, 8:171-184.
5. Claes I.J., Segers M.E., Verhoeven T.L., Dusselier M., Sels B.F., De Keersmaecker S.C., Vanderleyden J., Lebeer S. Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb. Cell Fact. 2012, 11:161.
6. Morath S., von Aulock S., Hartung T. Structure/function relationships of lipoteichoic acids. J. Endotoxin Res. 2005, 11:348-356.
7. Neuhaus F.C., Baddiley J. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 2003, 67:686-723.
8. Dessing M.C., Schouten M., Draing C., Levi M., von Aulock S., van der Poll T. Role played by toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. J. Infect. Dis. 2008, 197:245-252.
9. Lebeer S., Claes I.J., Vanderleyden J. Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol. 2012, 20:5-10.
10. Kim H.G., Lee S.Y., Kim N.R., Ko M.Y., Lee J.M., Yi T.H., Chung S.K., Chung D.K. Inhibitory effects of Lactobacillus plantarum lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumor necrosis factor-alpha production. J. Microbiol. Biotechnol. 2008, 18:1191-1196.
11. Quanxin G., Lili Q., Tianxing W., Tingting X., Jinbo W. Immunomodulatory effects of clostridium butyricum on human enterocyte-like HT-29 cells. Anim. Cells Syst. 2013, 17:121-126.
12. Gao Q., Qi L., Wu T., Wang J. Ability of clostridium butyricum to inhibit Escherichia coli-induced apoptosis in chick enembryo intestinal cells. Vet. Microbiol. 2012, 160:395-402.
13. Fischer W., Koch H.U., Haas R. Improved preparation of lipoteichoic acids. Eur. J. Biochem. 1983, 133:523-530.
14. Misawa Y., Kelley K.A., Wang X., Wang L., Park W.B., Birtel J., Saslowsky D., Lee J.C. Staphylococcus aureus colonization of the mouse gastrointestinal tract is modulated by wall teichoic acid, capsule, and surface proteins. PLoS Pathog. 2015, 11:e1005061.
15. Schlag M., Biswas R., Krismer B., Kohler T., Zoll S., Yu W., Schwarz H., Peschel A., Götz F. Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol. Microbiol. 2010, 75:864-873.
16. Haddadi S., Thapa S., Kameka A.M., Hui J., Czub M., Nagy E., Muench G., Abdul-Careem M.F. Toll-like receptor 2 ligand, lipoteichoic acid is inhibitory against infectious laryngotracheitis virus infection in vitro and in vivo. Dev. Comp. Immunol. 2015, 48:22-32.
17. Hong S.W., Baik J.E., Kang S.S., Yun C.H., Seo D.G., Han S.H. Lipoteichoic acid of Streptococcus mutans interacts with toll-like receptor 2 through the lipid moiety for induction of inflammatory mediators in murine macrophages. Mol. Immunol. 2014, 57:284-291.
18. Kim H.G., Kim N.R., Gim M.G., Lee J.M., Lee S.Y., Ko M.Y., Kim J.Y., Han S.H., Chung D.K. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice. J. Immunol. 2008, 180:2553-2561.
19. Kim H., Jung B.J., Jeong J., Chun H., Chung D.K. Lipoteichoic acid from Lactobacillus plantarum inhibits the expression of platelet-activating factor receptor induced by Staphylococcus aureus lipoteichoic acid or Escherichia coli lipopolysaccharide in human monocyte-like cells. J. Microbiol. Biotechnol. 2014, 24:1051-1058.
20. Han S.H., Kim J.H., Martin M., Michalek S.M., Nahm M.H. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating toll-like receptor 2. Infect. Immun. 2003, 71:5541-5548.
21. Schröder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zähringer U., Göbel U.B., Weber J.R., Schumann R.R. Lipoteichoic Acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via toll-like receptor (TLR)-2 lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 2003, 278:15587-15594.
22. Ryu Y.H., Baik J.E., Yang J.S., Kang S.S., Im J., Yun C.H., Kim D.W., Lee K., Chung D.K., Ju H.R., Han S.H. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int. Immunopharmacol. 2009, 9:127-133.
23. Kim H.G., Lee S.Y., Kim N.R., Lee H.Y., Ko M.Y., Jung B.J., Kim C.M., Lee J.M., Park J.H., Han S.H., Chung D.K. Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation. Mol. Immunol. 2011, 48:382-391.
24. Jang K.S., Baik J.E., Han S.H., Chung D.K., Kim B.G. Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. Biochem. Biophys. Res. Commun. 2011, 407:823-830.
25. Percy M.G., Gründling A. Lipoteichoic acid synthesis and function in gram-positive bacteria. Annu. Rev. Microbiol. 2014, 68:81-100.
26. Baik J.E., Jang K.S., Kang S.S., Yun C.H., Lee K., Kim B.G., Kum K.Y., Han S.H. Calcium hydroxide inactivates lipoteichoic acid from Enterococcus faecalis through deacylation of the lipid moiety. J. Endod. 2011, 37:191-196.
27. Koch L., Frommhold D., Buschmann K., Kuss N., Poeschl J., Ruef P. LPS- and LTA-induced expression of IL-6 and TNF-α in neonatal and adult blood: role of MAPKs and NF-κB. Mediators Inflamm. 2014, 2014:283126.
28. Huang B.R., Tsai C.F., Lin H.Y., Tseng W.P., Huang S.S., Wu C.R., Lin C., Yeh W.L., Lu D.Y. Interaction of inflammatory and anti-inflammatory responses in microglia by Staphylococcus aureus-derived lipoteichoic acid. Toxicol. Appl. Pharmacol. 2013, 269:43-50.
29. Tian Y., Zhang X., Zhang K., Song Z., Wang R., Huang S., Lin Z. Effect of Enterococcus faecalis lipoteichoic acid on apoptosis in human osteoblast-like cells. J. Endod. 2013, 39:632-637.
30. Wu B.Q., Luo J.M., Wang Y.H., Shi Y.F., Liu H., Ba J.H., Zhang T.T. Inhibitory effects of simvastatin on Staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages. Clin. Exp. Med. 2014, 14:151-160.